GLP‐1 Is a Coronary Artery Vasodilator in Humans

BACKGROUND: The mechanism underlying the beneficial cardiovascular effects of the incretin GLP‐1 (glucagon‐like peptide 1) and its analogues in humans is elusive. We hypothesized that activating receptors located on vascular smooth muscle cells to induce either peripheral or coronary vasodilatation...

Descripción completa

Detalles Bibliográficos
Autores principales: Clarke, Sophie J., Giblett, Joel P., Yang, Lucy L., Hubsch, Annette, Zhao, Tian, Aetesam‐ur‐Rahman, Muhammad, West, Nick E. J., O'Sullivan, Michael, Figg, Nichola, Bennett, Martin, Wewer Albrechtsen, Nicolai J., Deacon, Carolyn F., Cheriyan, Joseph, Hoole, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404441/
https://www.ncbi.nlm.nih.gov/pubmed/30571482
http://dx.doi.org/10.1161/JAHA.118.010321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404441/
https://www.ncbi.nlm.nih.gov/pubmed/30571482
http://dx.doi.org/10.1161/JAHA.118.010321

Ejemplares similares